Every recall we track for Akron Pharma, Inc. — 11 in all — plus the complaints and injury reports the public filed about them.
Akron Pharma recalls 1000-tablet acetaminophen bottles with incorrect labeling. Wrong ID on tablets may cause confusion with other products. Consumers should check NDC 71399-8022-02 and lot numbers.
Akron Pharma recalls 100-tablet acetaminophen extra strength 500mg bottles with incorrect labeling. This may lead to confusion about product identity.
Akron Pharma recalls 25mg diphenhydramine capsules with incorrect labeling that could lead to confusion about the product's identity.
Akron Pharma recalls 325mg acetaminophen tablets with incorrect labeling. Consumers should check for wrong ID imprints on the bottle.
Akron Pharma recalls 50mg diphenhydramine capsules with incorrect labeling. This could lead to confusion about the product's identity. Consumers should check the label and contact the company for details.
Akron Pharma recalls 25mg diphenhydramine capsules with incorrect labeling that may cause confusion about product identity. Consumers should check NDC 71399-8028-2 and lot number KDC0124002B for affected items.
Akron Pharma recalls 325mg acetaminophen tablets with incorrect labeling. Wrong ID on tablets may cause confusion with other products. Affected lots: KDT0124004-006, expiring 08/31/2026.
Akron Pharma recalls OneLAX Docusate Sodium Liquid due to CGMP deviations. Affected lots expire 10/2025 or 11/2025. No specific remedy stated in official notice.
Akron Pharma recalls 1% DIBUCAINE hemorrhoidal ointment due to missing lot and expiration dates. Consumers should check labels for correct dates to avoid potential safety issues.
Akron Pharma recalls extra-strength acetaminophen tablets with missing "AP 325" imprint. These tablets may be misidentified as different products, leading to incorrect dosing. Consumers should check for the imprint and contact the manufacturer for details.
